Navigation Links
Nektar Announces Restructuring to Complete Its Transition to a Therapeutics Drug Development Organization
Date:2/12/2008

ET. Information on the dial-in details and Webcast of the call will be posted on the Investor Relations section of the Nektar website, http://www.nektar.com.

About Nektar

Nektar Therapeutics is a biopharmaceutical company that develops and enables differentiated therapeutics with its industry-leading PEGylation and pulmonary drug development platforms. Nektar PEGylation and pulmonary technology, expertise, manufacturing capabilities have enabled ten approved products for partners, which include the world's leading pharmaceutical and biotechnology companies. Nektar also develops its own products by applying its PEGylation and pulmonary technology platforms to existing medicines with the objective to enhance performance, such as improving efficacy, safety and compliance.

This press release contains forward-looking statements regarding management's plans and expectations for Nektar's organizational development and impact on its business objectives and its proprietary and partner product candidates currently in clinical development. These forward-looking statements involve substantial risks and uncertainties, including but not limited to: (i) the company may not realize the anticipated benefits to its business from the organizational developments described in this press release, (ii) the risk of failure of any product candidate that is in clinical development and prior to regulatory approval, such as the NKTR-102, NKTR-118, and NKTR-061, remains high and can occur at any stage due to efficacy, safety or other factors, (iii) clinical trials for the company's proprietary product candidates such as NKTR-102, NKTR-118 and NKTR-061 are long, expensive and uncertain processes, (iv) the ability of the company to the to obtain regulatory approval of NKTR-102, NKTR-118 and NKTR-061 is difficult to predict at any stage of development, (v) the company's patent applications for its technology platforms and prop
'/>"/>

SOURCE Nektar Therapeutics
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Nektar Appoints Hoyoung Huh, M.D., Ph.D., to Serve on the Companys Board of Directors
2. Nektar Therapeutics President and CEO Howard W. Robin to Present At JPMorgan 26th Annual Healthcare Conference
3. Nektar Therapeutics to Present at 2007 BMO Capital Markets Focus on Healthcare Conference
4. Nektar Therapeutics President and CEO Howard Robin to Present at 2007 BIO InvestorForum
5. Drs. John Patton of Nektar, Igor Gonda of Aradigm, Tomas Landh of Novo Nordisk, Chris Rhodes of Amylin to Speak at iiBIGs Plenary Panel in Vegas
6. Nektar Presents Positive Results from Phase 1 Clinical Trial of NKTR-118 (oral PEG-naloxol) at American College of Clinical Pharmacology Meeting
7. Nektar Therapeutics Appoints Lutz Lingnau as New Board Member
8. Nektar Therapeutics Appoints Tim Harkness as Chief Financial Officer
9. PAREXEL International Announces 2-For-1 Stock Split
10. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
11. Elekta Announces First Volumetric Modulated Arc Therapy Cancer Treatment at Royal Marsden Hospital
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... Editor Note: For more information ... Moments ago, Analysts Review released new research updates concerning ... SSH ), Synergetics USA ... ELOS ), Spectranetics (NASDAQ: SPNC ), and Thoratec ... unified platform for investors, to hear about what matters - ...
(Date:3/2/2015)... Global Stem Cells Group.com ... HANK Bioengineering Co., Ltd. and its Chinese-American founder ... a stem cells training course in the City ... , Shenzhen HANK is a biotechnology company established ... and virologist, to integrate research, development, production, and ...
(Date:2/27/2015)... Halifax, Nova Scotia (PRWEB) February 27, 2015 ... has been made aware of a fraudulent press release ... GlobeNewswire, purporting to be from Immunovaccine. This press release ... with Gilead Science, Inc. The press release did ... to the information contained within the press release. ...
(Date:2/27/2015)... and Markets ( http://www.researchandmarkets.com/research/p2ddnr/global_market ) has announced the ... report to their offering. , Global Market ... on Trypsin globally and regionally ( Europe , ... , Latin America etc.). It captures ... This report focuses on three primary areas; manufacture methods & ...
Breaking Biology Technology:Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 2Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 3Quarterly Report Card of Biotechnology Companies: New Research on Sunshine Heart, Synergetics USA, Syneron Medical, Spectranetics and Thoratec 4Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 2Global Stem Cells Group Announces Alliance with HANK Bioengineering Co., Ltd. in Shenzhen, China 3Immunovaccine Disclaims Hoax Press Release 2Global Market Report of Trypsin 2014-2018 2
... Emisphere,Technologies, Inc. (Nasdaq: EMIS ) ... to the position of Vice President and ... will be responsible for the,overall planning, management ... intellectual property, transactional legal advice, securities and,funding, ...
... /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... in the manufacture,research, development, marketing and distribution ... signed an agreement with Bright Dairy & ... supply probiotics for Bright,Dairy,s ice cream products ...
... double annual sales, IDAHO FALLS, Idaho, Aug. ... announces it has entered into an,agreement with Alpha ... exclusive worldwide distributor for a new family of ... been working on the development and licensing of ...
Cached Biology Technology:Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel 2Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel 3Emisphere Technologies, Inc. Appoints Paul Lubetkin as Vice President and General Counsel 4China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 2China-Biotics, Inc. Signs Intention Agreement to Supply Probiotics to Bright Dairy & Food Co., Ltd. 3International Isotopes Inc. Announces Completion of an Exclusive Distributor Agreement for Sales of New Style Transportation Containers 2
(Date:1/22/2015)... Jan. 22, 2015 Research and Markets ( http://www.researchandmarkets.com/research/4trb7t/biometrics_a ... A Global Market Overview" report to their offering. ... to ensure that an individual is who she/he is claiming ... use of a person,s unique physical characteristics, such as fingerprint, ...
(Date:1/22/2015)... the leading source of biometrics industry news, interviews and thought ... "When we launched FindBiometrics 12 years ago the industry ... and CEO of FindBiometrics. "Now it,s maturing very quickly. More ... on a very broad scale.  We are known for providing ...
(Date:1/22/2015)... DETROIT , Jan. 13, 2015 Technology Showcase, Hall ... iris-based identity authentication solutions, today announced it will showcase its ... and developed by the Department of Energy,s Oak Ridge ... International Auto Show . EyeLock,s iris identity authentication technology is ...
Breaking Biology News(10 mins):Biometrics - A Global Market Overview 2Biometrics - A Global Market Overview 3Identity Industry Leading Publication Debuts New Look As Biometrics Hit Mainstream 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3
... team of University of Oregon biologists, using fruit flies, ... cells, opening a new window on how gene expression ... DNA (deoxyribonucleic acid) provides an identical genetic blueprint in ... turn protein molecules on and off in different cell ...
... variants associated with the age at which females experience ... may help shed light on the prevention of breast ... a new study, researchers from Harvard School of Public ... Institute (NCI), and the Broad Institute of Harvard and ...
... to particulate matter has been recognized as a contributing ... a new study indicates inhalation of certain particulates can ... the development and the outcome of cancers and other ... 17, at the 105th International Conference of the American ...
Cached Biology News:New tool isolates RNA within specific cells 2Study finds genetic links to age of first menstrual period and menopause 2Study finds genetic links to age of first menstrual period and menopause 3Environmental exposures may damage DNA in as few as three days 2
... Streptavidin-HRP Systems provide rapid, precise localization ... in frozen or paraffin-embedded tissue, cytospins ... also facilitate double or triple labeleing ... simultaneously with primary antibodies of different ...
... covers can be used with ... covers for stacking of covered ... for use with automated systems ... and non-ridged, are available for ...
... Whatever your Ion Chromatography requirements, ... plus more . The newly ... high sensitivities and exceptionally ultra-low drift ... continuous regeneration suppression creates even ...
... Provides a fast and easy method ... mitochondrial fraction from mammalian tissues. Most ... inner and outer membranes. The kit ... studies and proteome profiling. Also included ...
Biology Products: